123 related articles for article (PubMed ID: 2465820)
1. The premalignant nature of mouse skin papillomas: histopathologic, cytogenetic, and biochemical evidence.
Aldaz CM; Conti CJ
Carcinog Compr Surv; 1989; 11():227-42. PubMed ID: 2465820
[No Abstract] [Full Text] [Related]
2. Development of murine skin neoplasia studied with enzymes used as cell markers.
Reddy AL; Fialkow PJ
Carcinog Compr Surv; 1989; 11():213-26. PubMed ID: 2493335
[No Abstract] [Full Text] [Related]
3. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
[TBL] [Abstract][Full Text] [Related]
5. Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
Stern MC; Conti CJ
Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983
[No Abstract] [Full Text] [Related]
6. Sequential studies of skin tumorigenesis in phosphoglycerate kinase mosaic mice: effect of resumption of promotion on regressed papillomas.
Reddy AL; Caldwell M; Fialkow PJ
Cancer Res; 1987 Apr; 47(7):1947-51. PubMed ID: 3102053
[TBL] [Abstract][Full Text] [Related]
7. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion.
Darwiche N; Ryscavage A; Perez-Lorenzo R; Wright L; Bae DS; Hennings H; Yuspa SH; Glick AB
Oncogene; 2007 Oct; 26(48):6885-95. PubMed ID: 17525749
[TBL] [Abstract][Full Text] [Related]
9. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
Kruszewski FH; Conti CJ; DiGiovanni J
Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
11. Sequential development of aneuploidy, keratin modifications, and gamma-glutamyltransferase expression in mouse skin papillomas.
Aldaz CM; Conti CJ; Larcher F; Trono D; Roop DR; Chesner J; Whitehead T; Slaga TJ
Cancer Res; 1988 Jun; 48(11):3253-7. PubMed ID: 2452689
[TBL] [Abstract][Full Text] [Related]
12. The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis.
Tennenbaum T; Weiner AK; Belanger AJ; Glick AB; Hennings H; Yuspa SH
Cancer Res; 1993 Oct; 53(20):4803-10. PubMed ID: 8402665
[TBL] [Abstract][Full Text] [Related]
13. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
[TBL] [Abstract][Full Text] [Related]
14. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
Owens DM; Watt FM
Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
[TBL] [Abstract][Full Text] [Related]
15. Mathematical modeling of skin papilloma data in SENCAR mice.
Watanabe KH; Travis CC
Toxicol Appl Pharmacol; 1997 Dec; 147(2):419-30. PubMed ID: 9439737
[TBL] [Abstract][Full Text] [Related]
16. Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions.
Aldaz CM; Trono D; Larcher F; Slaga TJ; Conti CJ
Mol Carcinog; 1989; 2(1):22-6. PubMed ID: 2499343
[TBL] [Abstract][Full Text] [Related]
17. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses.
Meeran SM; Vaid M; Punathil T; Katiyar SK
Carcinogenesis; 2009 Mar; 30(3):520-8. PubMed ID: 19158151
[TBL] [Abstract][Full Text] [Related]
18. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis.
Miller DR; Viaje A; Rotstein J; Aldaz CM; Conti CJ; Slaga TJ
Cancer Res; 1989 Jan; 49(2):410-4. PubMed ID: 2491955
[TBL] [Abstract][Full Text] [Related]
19. Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.
Tennenbaum T; Lowry D; Darwiche N; Morgan DL; Gartsbein M; Hansen L; De Luca LM; Hennings H; Yuspa SH
Cancer Res; 1998 Apr; 58(7):1435-43. PubMed ID: 9537245
[TBL] [Abstract][Full Text] [Related]
20. A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas.
Pena JC; Rudin CM; Thompson CB
Cancer Res; 1998 May; 58(10):2111-6. PubMed ID: 9605754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
